Skip to main content

Table 5 Comparison of each test index in stages I-II and III-IV

From: Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer

Groups

Stage I-II

Stage III-IV

Z Value

P Value

N

112

181

t-PAIC (ng/mL)

4.02 (2.81,5.72)

4.78 (3.20,7.40)

-2.603

0.009

TM (TU/mL)

7.26 (5.13,10.88)

8.26 (6.08,12.02)

-2.324

0.02

TAT (ng/mL)

6.69 (3.75,9.15)

10.36 (6.90,15.34)

-6.455

<0.001

PIC (μg/mL)

0.52 (0.37,0.68)

0.86 (0.60,1.08)

-7.502

<0.001

D-D (mg/L)

0.38 (0.22,0.69)

1.59 (0.75,3.36)

-9.874

<0.001

FDP (mg/L)

2.20 (1.70,3.20)

5.40 (3.00,11.00)

-9.164

<0.001

  1. Abbreviation: GC Gastric cancer, t-PAIC Tissue plasminogen activator inhibitor complex, TAT Thrombin-antithrombin complex, TM Thrombomodulin, PIC Plasmin-α2-plamininhibitor complex, D-D D-Dimer, FDP Fibrinogen degradation product
  2. * P < 0.05 considered statistically significant